Humana Inc vs Zscaler Inc — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Zscaler Inc trades at $178.3 (market cap $28.57B). The key difference: Humana Inc is the larger of the two by market cap, and Humana Inc pays a 0.92% dividend while Zscaler Inc pays none. Which is the better fit depends on your goals.
| HUM | ZS | |
|---|---|---|
Market Cap | $46.31B | $28.57B |
Sector | Health | Technology |
52-Week High | $409.42 | $336.27 |
52-Week Low | $163.67 | $118.05 |
Enterprise Value | $53.67B | $26.89B |
Dividend Yield | 0.92% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Zscaler (ZS) trades at $168.68, up 3.74% on the day, exhibiting strong bullish momentum with a consensus analyst price target of $191.81. The stock shows robust revenue growth, with fiscal 2025 revenue reaching $2.67 billion, though it remains unprofitable with a net income margin of -2.44%. Recent positive developments include being named a Leader in the 2026 Gartner Magic Quadrant for SASE and Security Service Edge, and consistently beating earnings expectations in recent quarters.
The outlook is cautiously optimistic, driven by strong secular trends in cybersecurity and Zero Trust adoption. The primary investment opportunity lies in the company's high revenue growth and market leadership. Key risks include persistent profitability challenges, high valuation multiples like an EV/EBITDA of 177.75, and intense competition in the cybersecurity sector. The stock's near-term performance will be heavily influenced by the upcoming Q2 2026 earnings report.
Trailing returns across standard periods
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →